Company / Shares Outstanding
Alaunos Therapeutics, Inc. Shares Outstanding History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
1.6M
FY2025
5-year range
1.6M / 216.1M
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from 16027384.00 to 1601252.00 over the past 2 years.
Based on SEC 10-K filings.
1601252.00 in FY2025 with a 5-year CAGR of -61.2%.
Improved from 16027384.00 to 1601252.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -80.5%
- 5-Year CAGR
- -61.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shares outstanding increased 0.0% year-over-year.
- Peak shares outstanding was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 1.6M | +0.0% |
| FY2024 | 1.6M | -90.0% |
| FY2023 | 16.0M | -92.6% |
| FY2022 | 216.1M | +0.7% |
| FY2021 | 214.6M | +18.0% |
| FY2020 | 181.8M | +12.9% |
| FY2019 | 161.1M | +12.9% |
| FY2018 | 142.7M | +71.4% |
| FY2013 | 83.2M | +20.3% |
| FY2012 | 69.2M | +42.8% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026